相关实验视频

Updated: Sep 10, 2025

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

基于溶液的研究,研究了补充受体3连接体结合域与simvastatin之间的接触

Morten Hulbæk Fog¹, Violaine Hubert², Corinne Sanglar³

¹Biophysical Immunology Laboratory, Dept. of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark.

Biochimica et biophysica acta. Proteins and proteomics

|August 20, 2025

概括

西姆瓦斯塔丁是一种

科学领域:

药理学药理学是指药理学的学科.
免疫学免疫学免疫学
生物化学生物化学

背景情况:

降胆固醇药物西姆瓦斯塔丁通过向CD18整合素,表现出抗炎作用.
淋巴细胞相关抗原 (LFA) -1 和补充受体3 (CR3) 是参与免疫反应的关键CD18整合素.
已经提出了simvastatin对LFA-1和CR3的抑制机制,但需要进一步阐明.

研究的目的:

调查simvastatin抑制LFA-1和CR3.3的独特机制.
在CR3.3上比较simvastatin的乳 (simvastatin-lac) 和碳酸盐 (simvastatin-carbox) 形式的抑制作用.
评估simvastatin-carbox抑制对CR3介导功能的功能后果以及体内中风模型中的功能后果.

主要方法:

对simvastatin-carbox用于αM整合素I (αMI) 域的亲和度测量 (K_D).
抑制CR3与iC3b结合的测定.
在中脑动脉封闭 (MCAO) 动物模型中评估simvastatin的神经保护和抗炎作用.

主要成果:

对于αMI域,simvastatin-carbox表现出较弱的亲和力 (K_D ≈ 650 μM),明显低于simvastatin-lac的抑制度 (50 μM).
在MCAO中风模型中,simvastatin-carbox没有抑制CR3与iC3b的结合,并且缺乏有效性.
辛巴斯塔丁-拉克通过明显的全osteric 和潜在的三元复杂介导机制有效地抑制了LFA-1 和CR3.

结论:

西姆瓦斯塔丁-拉克通过对αI域的全结合来对抗LFA-1.
辛巴斯塔丁-拉克通过一种独特的机制抑制CR3,涉及三元复合体的形成,碳酸盐形式表现出较弱的亲和力.
在之前的研究中观察到的抗炎和神经保护作用可能归因于simvastatin-lac,而不是simvastatin-carbox.

关键词:

反对主义的对抗主义.补充受体 3 补充受体 3 我域名域名整体的整体是整体的西姆瓦斯塔丁是一种一次性中风,中风.

更多相关视频

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

相关概念视频

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...